{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:32:42Z","timestamp":1770676362405,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T00:00:00Z","timestamp":1176940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T00:00:00Z","timestamp":1176940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1038\/sj.jp.7211745","type":"journal-article","created":{"date-parts":[[2007,4,19]],"date-time":"2007-04-19T05:38:50Z","timestamp":1176961130000},"page":"329-334","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Low-molecular-weight heparin in pregnancy: peripartum bleeding complications"],"prefix":"10.1038","volume":"27","author":[{"given":"M A","family":"Kominiarek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S M","family":"Angelopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N L","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Studee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E A","family":"Nutescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J U","family":"Hibbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,19]]},"reference":[{"key":"BF7211745_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1055\/s-0038-1655903","volume":"77","author":"BJ Hunt","year":"1997","unstructured":"Hunt BJ, Doughty HA, Majumdar G, Copplestone A, Kerslake S, Buchanan N et al. Thromboprophylaxis with low molecular weight heparin (fragmin) in high risk pregnancies. Thromb Haemost 1997; 77: 39\u201343.","journal-title":"Thromb Haemost"},{"issue":"Suppl","key":"BF7211745_CR2","first-page":"2:24","volume":"26","author":"A Frydman","year":"1996","unstructured":"Frydman A . Low-molecular-weight-heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans. Haemostasis 1996; 26 (Suppl): 2:24\u20132:38.","journal-title":"Haemostasis"},{"key":"BF7211745_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/bmj.309.6950.299","volume":"309","author":"A Leizorovicz","year":"1994","unstructured":"Leizorovicz A, Simonneau G, Decousus H, Boissel JP . Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep vein thrombosis: a meta-analysis. Br Med J 1994; 309: 299\u2013304.","journal-title":"Br Med J"},{"key":"BF7211745_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archinte.1995.00430060059007","volume":"155","author":"AWA Lensing","year":"1995","unstructured":"Lensing AWA, Prins MH, Davidson BL, Hirsh J . Treatment of deep venous thrombosis with low molecular weight heparins: a meta-analysis. Arch Intern Med 1995; 155: 601\u2013607.","journal-title":"Arch Intern Med"},{"key":"BF7211745_CR5","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0002-9343(97)89484-3","volume":"100","author":"S Siragusa","year":"1996","unstructured":"Siragusa S, Cosmi B, Piovella F, Hirsh J, Ginsberg JS . Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med 1996; 100: 269\u2013277.","journal-title":"Am J Med"},{"key":"BF7211745_CR6","first-page":"4","volume":"3","author":"L Dolovich","year":"1997","unstructured":"Dolovich L, Ginsberg JS . Low molecular weight heparin in the treatment of venous thromboembolism: an updated meta-analysis. Vessels 1997; 3: 4\u201311.","journal-title":"Vessels"},{"key":"BF7211745_CR7","doi-asserted-by":"publisher","first-page":"800","DOI":"10.7326\/0003-4819-130-10-199905180-00003","volume":"130","author":"MK Gould","year":"1999","unstructured":"Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM . Low molecular weight heparins compared with unfractionated heparin for treatment of acute deep vein thrombosis: a meta-analysis of randomized, controlled trials. Ann Intern Med 1999; 130: 800\u2013809.","journal-title":"Ann Intern Med"},{"key":"BF7211745_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-0037-1612970","volume":"87","author":"V Pettila","year":"2002","unstructured":"Pettila V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R . Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002; 87: 182\u2013186.","journal-title":"Thromb Haemost"},{"key":"BF7211745_CR9","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199505183322003","volume":"332","author":"TE Warkentin","year":"1995","unstructured":"Warkentin TE, Levine MN, Hirsh J, Horsewood P, Roberts RS, Gent M et al. Heparin induced thrombocytopenia in patients treated with low molecular weight heparin or unfractionated heparin. N Eng J Med 1995; 332: 1330\u20131335.","journal-title":"N Eng J Med"},{"key":"BF7211745_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2165\/00003495-200262030-00004","volume":"62","author":"P Laurent","year":"2002","unstructured":"Laurent P, Dussarat GV, Bonal J, Jego C, Talard P, Bouchiat C et al. Low molecular weight heparins: a guide to their optimum use in pregnancy. Drugs 2002; 62: 463\u2013477.","journal-title":"Drugs"},{"key":"BF7211745_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/0049-3848(84)90260-3","volume":"34","author":"F Forestier","year":"1984","unstructured":"Forestier F, Daffos F, Capella-Pavlovsky M . Low molecular weight heparin does not cross the placenta during the second trimester of pregnancy: study by direct fetal blood sampling under ultrasound. Thromb Res 1984; 34: 557\u2013560.","journal-title":"Thromb Res"},{"key":"BF7211745_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1055\/s-0038-1651102","volume":"57","author":"F Forestier","year":"1987","unstructured":"Forestier F, Daffos F, Rainaut M, Toulemonde F . Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thromb Haemost 1987; 57: 234.","journal-title":"Thromb Haemost"},{"key":"BF7211745_CR13","first-page":"845","volume":"100","author":"Safety of lovenox in pregnancy","year":"2002","unstructured":"Safety of lovenox in pregnancy. ACOG committee opinion no. 276. American college of obstetricians and gynecologists. Obstet Gynecol 2002; 100: 845\u2013846.","journal-title":"Obstet Gynecol"},{"key":"BF7211745_CR14","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1055\/s-0037-1614550","volume":"5","author":"BJ Sanson","year":"1999","unstructured":"Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost 1999; 5: 668\u2013672.","journal-title":"Thromb Haemost"},{"key":"BF7211745_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1592\/phco.19.13.1013.31588","volume":"19","author":"MH Ensom","year":"1999","unstructured":"Ensom MH, Stephenson MD . Low-molecular-weight heparins in pregnancy. Pharmacotherapy 1999; 19: 1013\u20131025.","journal-title":"Pharmacotherapy"},{"key":"BF7211745_CR16","doi-asserted-by":"publisher","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","volume":"126","author":"SM Bates","year":"2004","unstructured":"Bates SM, Greer IA, Hirsh J, Ginsberg JS . Use of antithrombotic agents during pregnancy. Chest 2004; 126: 627S\u2013644S.","journal-title":"Chest"},{"issue":"Suppl","key":"BF7211745_CR17","first-page":"164","volume":"23","author":"TT Horlocker","year":"1998","unstructured":"Horlocker TT, Wedel DJ . Neuraxial block and low-molecular-weight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med 1998; 23 (Suppl): 164\u2013177.","journal-title":"Reg Anesth Pain Med"},{"key":"BF7211745_CR18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1213\/00000539-199801000-00051","volume":"86","author":"TT Horlocker","year":"1998","unstructured":"Horlocker TT, Wedel DJ . Spinal and epidural blockade and perioperative low molecular weight heparin: smooth sailing on the titanic. Anesth Analg 1998; 86: 1153\u20131156.","journal-title":"Anesth Analg"},{"key":"BF7211745_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/bja\/82.2.164","volume":"82","author":"MR Checketts","year":"1999","unstructured":"Checketts MR, Wildsmith JAW . Central nerve block and thromboprophylaxis \u2013 is there a problem? Br J Anaesth 1999; 82: 164\u2013167.","journal-title":"Br J Anaesth"},{"key":"BF7211745_CR20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1097\/01.ogx.0000180909.31293.cf","volume":"60","author":"AJG Jansen","year":"2005","unstructured":"Jansen AJG, van Rhenen DJ, Steegers EAP, Duvekot JJ . Postpartum hemorrhage and transfusion of blood and blood components. Obstet Gynecol Surv 2005; 60: 663\u2013671.","journal-title":"Obstet Gynecol Surv"},{"key":"BF7211745_CR21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","volume":"176","author":"C Nelson-Piercy","year":"1997","unstructured":"Nelson-Piercy C, Letsky EA, deSwiet M . Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997; 176: 1062\u20131068.","journal-title":"Am J Obstet Gynecol"},{"key":"BF7211745_CR22","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1471-0528.2000.tb11110.x","volume":"107","author":"J Ellison","year":"2000","unstructured":"Ellison J, Walker ID, Greer IA . Antenatal use of enoxaparin for prevention and treatment of thromboembolism in pregnancy. BJOG 2000; 107: 1116\u20131121.","journal-title":"BJOG"},{"key":"BF7211745_CR23","first-page":"1134","volume":"108","author":"J Lepercq","year":"2001","unstructured":"Lepercq J, Conard J, Borel-Derlon A, Darmon JY, Boudignat O, Francoual C et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies. BJOG 2001; 108: 1134\u20131140.","journal-title":"BJOG"},{"key":"BF7211745_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1046\/j.0004-8666.2003.00034.x","volume":"43","author":"JA Rowan","year":"2003","unstructured":"Rowan JA, McLintock C, Taylor RS, North RA . Prophylactic and therapeutic enoxaparin during pregnancy: indications, outcomes, and monitoring. Aust N Z J Obstet Gynecol 2003; 43: 123\u2013128.","journal-title":"Aust N Z J Obstet Gynecol"},{"key":"BF7211745_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/14767050400028626","volume":"17","author":"S Maslovitz","year":"2005","unstructured":"Maslovitz S, Many A, Landsberg JA, Varon D, Lessing JB, Kupferminc MJ . The safety of low molecular weight heparin therapy during labor. J Matern Fetal Neonatl Med 2005; 17: 39\u201343.","journal-title":"J Matern Fetal Neonatl Med"},{"key":"BF7211745_CR26","unstructured":"Thromboembolism in pregnancy. ACOG practice bulletin no. 19. American College of Obstetricians and Gynecologists. Obstet Gynecol 2000; 96."},{"key":"BF7211745_CR27","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.fertnstert.2005.03.048","volume":"84","author":"B Brenner","year":"2005","unstructured":"Brenner B, Bar J, Ellis M, Yarom I, Yohai D, Samueloff A, Live-Enox Investigators. Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox study. Fertil Steril 2005; 84: 770\u2013773.","journal-title":"Fertil Steril"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7211745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7211745","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7211745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T16:34:56Z","timestamp":1647621296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7211745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,19]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["BF7211745"],"URL":"https:\/\/doi.org\/10.1038\/sj.jp.7211745","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,19]]},"assertion":[{"value":"11 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}